Literature DB >> 17531350

Hydrogen peroxide attenuates insulin-like growth factor-1 neuroprotective effect, prevented by minocycline.

Jin Zhong1, Wei-Hua Lee.   

Abstract

Oxidative stress-induced neuronal death due to hydrogen peroxide overload plays a critical role in the pathogenesis of numerous neurological diseases. Insulin-like growth factor-1 (IGF-1) is important in maintaining neuronal survival, proliferation, and differentiation in the central nervous system. We now report that sublethal doses of hydrogen peroxide attenuated IGF-1 neuroprotective activity on cultured cerebellar granule neurons under potassium and serum deprivation. Interestingly, this attenuation can be prevented by minocycline, an antibiotic that has been shown to have neuroprotective activity in animal models of neuronal injury. Furthermore, hydrogen peroxide also blocked IGF-1's neuroprotection for cortical neurons deprived of neurotrophic factors (B27), which was prevented by minocycline. Our data suggest that inhibition of IGF-1 signaling by hydrogen peroxide may constitute an additional pathway contributing to its neurotoxicity. More importantly, combining minocycline and IGF-1 could be an effective treatment in neurological diseases associated with both oxidative stress and deficiency of IGF-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531350     DOI: 10.1016/j.neuint.2007.04.005

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  14 in total

1.  Profile of minocycline neuroprotection in bilirubin-induced auditory system dysfunction.

Authors:  Ann C Rice; Victoria L Chiou; Sarah B Zuckoff; Steven M Shapiro
Journal:  Brain Res       Date:  2010-11-12       Impact factor: 3.252

Review 2.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

Review 3.  Minocycline: therapeutic potential in psychiatry.

Authors:  Olivia M Dean; João Data-Franco; Francesco Giorlando; Michael Berk
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

Review 4.  Aging, atherosclerosis, and IGF-1.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Asif Anwar; Shaw-Yung Shai; Patrice Delafontaine
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-05       Impact factor: 6.053

5.  Neuronal death by oxidative stress involves activation of FOXO3 through a two-arm pathway that activates stress kinases and attenuates insulin-like growth factor I signaling.

Authors:  David Dávila; Ignacio Torres-Aleman
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

Review 6.  IGF-1, oxidative stress and atheroprotection.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Asif Anwar; Shaw-Yung Shai; Patrice Delafontaine
Journal:  Trends Endocrinol Metab       Date:  2010-01-12       Impact factor: 12.015

7.  Minocycline attenuates brain tissue levels of TNF-α produced by neurons after prolonged hypothermic cardiac arrest in rats.

Authors:  Tomas Drabek; Andreas Janata; Caleb D Wilson; Jason Stezoski; Keri Janesko-Feldman; Samuel A Tisherman; Lesley M Foley; Jonathan D Verrier; Patrick M Kochanek
Journal:  Resuscitation       Date:  2014-02       Impact factor: 5.262

8.  Astrocyte Resilience to Oxidative Stress Induced by Insulin-like Growth Factor I (IGF-I) Involves Preserved AKT (Protein Kinase B) Activity.

Authors:  David Dávila; Silvia Fernández; Ignacio Torres-Alemán
Journal:  J Biol Chem       Date:  2015-12-02       Impact factor: 5.157

9.  The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation.

Authors:  Dora Brites
Journal:  Front Pharmacol       Date:  2012-05-29       Impact factor: 5.810

10.  Anthraquinone-2-sulfonic acid (AQ2S) is a novel neurotherapeutic agent.

Authors:  T C Jackson; J D Verrier; P M Kochanek
Journal:  Cell Death Dis       Date:  2013-01-10       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.